FdaApplication
NDA 210303
Identifiers
- fda_app_no: NDA210303
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA USA INC |
| application_type | NDA |
| approval_date | 2018-06-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZEMDRI | PLAZOMICIN SULFATE | EQ 500MG BASE/10ML (EQ 50MG BASE/ML) | SOLUTION;INTRAVENOUS |
1 product